Mesoblast’s lead drug candidate to treat COVID-19 has been granted fast track designation from the United States Food and Drug … Read More
The post Mesoblast COVID-19 therapy granted fast-track designation appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.